Project documents | Avapritinib for treating inadequately controlled moderate to severe indolent systemic mastocytosis [ID6578] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 141 KB)

Published:

23 September 2025
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 460 KB)

Published:

23 September 2025
Equality impact assessment (scoping) (PDF 120 KB)

Published:

23 September 2025
Final stakeholder list (PDF 152 KB)

Published:

23 September 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Provisional stakeholder list post referral (PDF 144 KB)

Published:

05 August 2025
Draft scope post referral (PDF 147 KB)

Published:

05 August 2025